Copyright
©The Author(s) 2024.
World J Virol. Jun 25, 2024; 13(2): 90668
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.90668
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.90668
Table 5 Risk of electrocardiogram pattern changes (QTc prolongation) in each subgroup
Variables | QTc prolongation | P value | |
Day 1, n = 261 | Day 14, n = 258 | ||
Men | 0 | 1 | 0.500 |
Women | 0 | 4 | 0.061 |
Age < 40 yr | 0 | 5 | 0.031 |
Obesity | 0 | 2 | 0.247 |
Normal and overweight | 0 | 3 | 0.124 |
CtN2 or CtE < 33 | 0 | 5 | 0.030 |
HCQ-AZI | 0 | 5 | 0.030 |
- Citation: Madioko Makanzu B, Makulo JR, Ndona Mandina M, Wumba DR, Mashi Longokolo M, Situakibanza H, Odio O, Sonzi Mangala D, Mihigo Bashengezi C, Kabwe Mwilambwe B, Kabanda Kurhenga G, Longo-Mbenza B, Mwimba Mbungu R. Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality? World J Virol 2024; 13(2): 90668
- URL: https://www.wjgnet.com/2220-3249/full/v13/i2/90668.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i2.90668